Maxime Dely: The Human Eye – Irreplaceable Guardian of Blood Transfusion
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“The human eye: Irreplaceable guardian of blood transfusion
In an era where artificial intelligence is revolutionizing medicine and robotization is transforming our laboratories, one field remains steadfast: visual control in blood transfusion.
Colorimetry: diagnosis at a glance
Every blood product tells a story through its color.
Turbid plasma? It’s lipemic.. A greenish tint? Trace of oral contraceptives. A pinkish coloration? Sign of hemolysis.
These instant observations guide our daily decisions.
Red blood cell concentrates reveal their quality through the coloration of the supernatant after storage. Simple, yet no machine can replace this human vigilance.
Swirling: when platelets dance
The most fascinating control? Platelet “swirling” – that whirling dance observed with the naked eye that testifies to their viability. An absent movement immediately alerts to degradation.
The leuko-platelet layer, with its creamy hue, also provides information on residual platelet quantity.
Expertise that cannot be digitized
These visual controls are essential safety barriers. Each professional develops a particular acuity, an abilty to perceivesubtle nuances.
This expertise is transmitted, refined – but cannot be robotized.
Blood transfusion illustrates the perfect balance between technology and human expertise. Automated systems optimize, IT systems trace, but it’s the trained eye that validates final quality.
Let’s value this human dimension
Behind every transfused bag lies the attentive gaze of a professional. In blood transfusion, the human eye remains our most precious safety instrument.”
Get the latest from Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis